Prophema

Prophema is a pre-launch CRO and regulatory consulting services firm founded in 2020 and headquartered in New Haven, Connecticut, with a disclosed 11–50 headcount. No service catalog, pricing model, customer base, or underlying technology has been publicly disclosed.

Company typePrivate
Founded2020
HeadquartersNew Haven, United States
Headcount11–50
GTM typeB2B
OfferingServices

What Prophema does

Prophema is a contract research organization (CRO) and regulatory consulting services firm headquartered in New Haven, Connecticut. Founded in 2020, the company operates with a disclosed headcount of 11–50 employees, although no management roster, founders, or detailed organizational structure have been made public. Its stated business focus is providing CRO and regulatory advisory services — categories that typically serve pharmaceutical, biotech, medical device, and broader life-sciences clients seeking clinical-trial support, regulatory submissions, and compliance consulting — though target customer segments, vertical emphasis, and service scope have not been publicly defined. The firm's website is reachable at prophema.com.

The company's product offerings, platform architecture, and underlying technology are not publicly disclosed. Core technology is listed as 'Not publicly disclosed' across all data sources, and no proprietary features, integrations, API surface, AI/ML capabilities, patents, trademarks, or compliance certifications have been reported. There is no evidence of a software platform or productized technology layer, and the business appears to be a services organization consistent with the CRO/consulting category. The website currently functions only as a landing page displaying a 'Launching Soon' message, a contact form for inbound inquiries, and an email newsletter signup for 'updates, promotions, and more,' indicating the firm is in a pre-commercial phase with no live service catalog.

Prophema's revenue model, pricing structure, distribution channels, and go-to-market approach are all listed as undisclosed, consistent with pre-launch posture. No select customers, case studies, partnership agreements, awards, or funding events have been reported. The firm has not disclosed an investor base, ownership structure, parent entity, or M&A history. The only confirmed commercial surface is the email capture form on the website, suggesting Prophema is currently in a brand-building and demand-capture phase ahead of a formal launch.

Prophema firmographics

Firmographics

Name: Prophema
Legal name: Prophema
Website: https://prophema.com
Company type: Private
Founded year: 2020
Operating status: Operating
Headcount range: 11–50 employees
Short description: Prophema is a pre-launch CRO and regulatory consulting services firm founded in 2020 and headquartered in New Haven, Connecticut, with a disclosed 11–50 headcount. No service catalog, pricing model, customer base, or underlying technology has been publicly disclosed.
Ownership category
akta.pro rank

Where Prophema is headquartered

Location

Headquarters

HQ city: New Haven
HQ country: United States
HQ region: North America

Markets served

Prophema business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel

Prophema product offering

Product offering

Core offering

Prophema operates as a contract research organization (CRO) and regulatory consulting services provider based in New Haven, United States. The firm is positioned to deliver outsourced research and regulatory affairs support to organizations in regulated industries. The company is currently in a pre-launch/launching-soon phase, with its website displaying only a 'Launching Soon' notice and a contact form.

Differentiator

Problem solved

Functional benefit

Companies that use Prophema

Customer profile

Ideal customer profiles1 record

Prophema technology and API

Technology

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Prophema partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Prophema competitors and assessment

Company assessment

Direct peers

Medpace: Medpace is a mid-to-large CRO focused on full-service clinical development for small-to-mid biotech sponsors. It directly competes for outsourced clinical and regulatory engagements in the segments where a small consulting-focused CRO like Prophema would operate.
ProPharma Group: ProPharma Group is a consulting and regulatory services firm focused on pharma, biotech, and medical device compliance, regulatory affairs, and quality. It is a near-direct competitor to Prophema for outsourced regulatory consulting engagements.
PharmaLex (now part of Cencora): PharmaLex is a regulatory and compliance consulting firm serving pharma and biotech with services from development through commercialization. Its consulting-led, regulatory-services model closely matches Prophema's stated positioning.
Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO providing clinical and bioanalytical services with deep expertise in complex therapeutic areas — a comparable competitor for sponsors engaging boutique CROs.

Broad incumbents

IQVIA: IQVIA is the largest global CRO and life-sciences services firm, offering clinical operations, regulatory affairs, and real-world evidence. It is the dominant incumbent against which Prophema, as a CRO and regulatory consulting services company, would compete.
Syneos Health: Syneos Health is a global clinical and commercial solutions provider offering CRO services alongside consulting and regulatory support. It represents a comparable service breadth to what Prophema's CRO and regulatory consulting positioning targets.
Charles River Laboratories: Charles River is a leading nonclinical CRO providing discovery, safety assessment, and manufacturing support to early-stage biopharma — a peer to Prophema for sponsors seeking outsourced R&D and regulatory support.
ICON plc: ICON is a major global CRO providing clinical research, regulatory, and consulting services to pharma/biotech sponsors. It directly competes with Prophema for outsourced clinical and regulatory work across sponsor segments.
Parexel International: Parexel is a large CRO with strong regulatory consulting and clinical trial services for biopharma. Its regulatory affairs and clinical operations offerings closely overlap with Prophema's stated CRO and regulatory consulting focus.

Emerging players

MMS Holdings: MMS is a specialty clinical and regulatory services firm focused on data management, biostatistics, and regulatory submissions for small-to-mid pharma. It overlaps with Prophema's regulatory consulting positioning, especially for niche sponsor work.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat1 record

Key risks6 records

Key highlights4 records

Customer concentration

Prophema financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Prophema leadership team

Management profile

Number of profiles

Prophema funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Prophema M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prophema

What does Prophema do?

When was Prophema founded?

Prophema was founded in 2020. It employs 11 to 50 people.

Where is Prophema based?

Prophema is headquartered in New Haven, United States, in the North America region.

Who are Prophema's main competitors?

Direct peers on record are Medpace, ProPharma Group, PharmaLex (now part of Cencora) and Worldwide Clinical Trials. Broad incumbents are IQVIA, Syneos Health, Charles River Laboratories, ICON plc and Parexel International. MMS Holdings is listed as an emerging player.

Does Prophema have an API?

No public API is recorded for Prophema.